Case Study

Accelerate European Market Access With Compliant And Comprehensive MAA Submission

Source: ProPharma
Digital-marketing-GettyImages-1051659276

Obtaining approval to place a medicinal product in the European market requires a license, a process overseen by the European Medicines Agency (EMA). Meeting EMA's requirements for a Marketing Authorization Application (MAA) involves numerous complex tasks, including building a Pharmacovigilance System Master File (PSMF), developing a Risk Management Plan (RMP), and registering for EudraVigilance. Additionally, assigning an EU Qualified Person for Pharmacovigilance (QPPV) and a Local Person responsible for Pharmacovigilance (LPPV) in certain countries is legally required.

Lacking in-house expertise and experience to navigate these requirements can lead to costly delays in achieving a successful submission of your MAA. ProPharma's extensive knowledge and network in EU QPPV and LPPV, coupled with our deep understanding of the MAA process, streamline this complex process, saving you valuable time and effort.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader